Home > Insider Trading > Filing (0001209191-10-039271)

Filing Details

Accession Number:: 0001209191-10-039271
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-07-21 13:00:00
Reporting Period:: 2010-07-19

Filing Date:: 2010-07-21
Accepted Time:: 2010-07-21 18:50:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1254419	Medassets Inc	MDAS	Services-Prepackaged Software (7372)	510391128

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1058190	F Bruce Wesson	C/O Galen Management, L.l.c. 680 Washington Blvd. Stamford CT 06901		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-07-19	12,150	$24.06	5,550,777	No	4	S	Indirect	See FN
Common Stock	Disposition	2010-07-20	20,400	$24.08	5,530,377	No	4	S	Indirect	See FN
Common Stock	Disposition	2010-07-21	900	$24.07	5,529,477	No	4	S	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See FN
No	4	S	Indirect	See FN
No	4	S	Indirect	See FN

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	54,783	Direct

Footnotes

The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009
The shares were sold as follows: 2,137 by Galen Partners IV, L.P. ("Galen IV"), 170 shares by Galen Partners International IV, L.P. ("Galen International IV"), 3 by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 8,994 by Galen Partners III, L.P. ("Galen III"), 815 by Galen Partners International III, L.P. ("Galen International III") and 31 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds").
The shares were sold at prices between $24.06 and $24.11. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 975,750 by Galen IV, 77,512 by Galen International IV, 1,359 by Employee Fund IV, 4,106,245 by Galen III, 372,135 by Galen International III and 17,776 by Employee Fund III. Claudius IV, L.L.C. ("Claudius IV") serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
Claudius, L.L.C. ("Claudius") serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. The Reporting Person is a member of Claudius IV, a member of Claudius and the sole shareholder of Wesson Enterprises. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein.
The shares were sold as follows: 3,588 shares by Galen IV, 285 shares by Galen International IV, 5 shares by Employee Fund IV, 15,101 shares by Galen III, 1,369 shares by Galen International III and 52 shares by Employee Fund III.
The shares were sold at prices between $24.06 and $24.16. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 972,162 by Galen IV, 77,227 by Galen International IV, 1,354 by Employee Fund IV, 4,091,144 by Galen III, 370,766 by Galen International III and 17,724 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
The shares were sold as follows: 158 shares by Galen IV, 13 shares by Galen International IV, 1 share by Employee Fund IV, 666 shares by Galen III, 60 shares by Galen International III and 2 shares by Employee Fund III.
The shares were sold at prices between $24.06 and $24.13. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 972,004 by Galen IV, 77,214 by Galen International IV, 1,353 by Employee Fund IV, 4,090,478 by Galen III, 370,706 by Galen International III and 17,722 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.